Prevalence Of Venous Thromboembolic Events Is Low In Asians After Total Knee Arthroplasty Without Chemoprophylaxis

Abstract Background This retrospective cohort study was designed to establish the prevalence of clinically significant venous thromboembolic events (VTE) in our patients undergoing total knee arthroplasty (TKA) without chemoprophylaxis. Methods A single-surgeon cohort of patients who underwent TKA f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of arthroplasty 2017-03, Vol.32 (3), p.974-979
Hauptverfasser: Bin Abd Razak, Hamid Rahmatullah, MBBS, MRCS, Dip SpMed, MMed (Ortho), Binte Abd Razak, Noorul Faeyza, MBBS, Tan, Hwee-Chye Andrew, MBBS, FRCS (Glasgow), FRCS Ed (Ortho)
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background This retrospective cohort study was designed to establish the prevalence of clinically significant venous thromboembolic events (VTE) in our patients undergoing total knee arthroplasty (TKA) without chemoprophylaxis. Methods A single-surgeon cohort of patients who underwent TKA from 2006 to 2014 were included. All patients had a pneumatic tourniquet applied and a drain inserted postoperatively. Tranexamic acid was not used perioperatively. All patients were under a standardized postoperative protocol with routine mechanical prophylaxis against VTE. None of the patients received prophylactic anticoagulation. All patients ambulated on the second postoperative day. Only symptomatic patients were referred for radiological examination to exclude VTE. We evaluated the patient demographics and calculated the prevalence of VTE in our cohort. Results A total of 966 patients were reviewed. Mean age was 66.1±7.8 years. Mean body mass index (BMI) was 28.2±4.7 kg/m2 . Mean tourniquet time was 53±23 minutes. Patients stayed in-hospital for a mean of 5.4±3.1 days. There was 100% compliance to mechanical prophylaxis. 11.1% of our patients were on concomitant antiplatelet or anticoagulant use. There were 8 patients with clinically significant VTE. This translates to a prevalence of 0.82%. Seven patients developed deep vein thrombosis (DVT) and 1 patient died from massive pulmonary embolism (PE). Conclusion The prevalence of clinically significant VTE in our patients who underwent TKA without routine chemoprophylaxis is 0.82%. With proper patient selection, risk stratification and stringent perioperative protocols, routine chemoprophylaxis may not be necessary in Asians undergoing TKA.
ISSN:0883-5403
1532-8406
DOI:10.1016/j.arth.2016.09.008